financetom
Business
financetom
/
Business
/
Uniphore to hire 300 employees globally, 200 in India alone
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uniphore to hire 300 employees globally, 200 in India alone
Sep 13, 2019 10:04 AM

Less than a month since artificial intelligence and tech firm Uniphore, announced it had secured 51 million USD in Series-C funding, the company has given a glimpse of its proposed investment roadmap to CNBC-TV18.com.

“Our largest funding till date allows us to push in multiple different directions, especially in markets like North Africa, Japan, Australia and Asia,” said Uniphore co-founder and President (APAC), Ravi Saraogi. In India, Uniphore is applying special emphasis on expansion, especially on the talent acquisition front. “We hope to employ 300 people by the end of 2019, 200 of whom will be hired in India alone,” Ravi added, “Around 50 to 60 of our new talent will be based in the US, Asia-Pacific and Europe by the end of this period.”

A significant portion of Uniphore’s Series C funding of 51 million USD, led by March Capital Partners will be dedicated to enhancing domain presence in HR, engineering and delivery — again out of India. “The idea is to keep growing revenues, expand our base and capture overall market share in the region,” said Ravi.

In August, Uniphore CEO, Umesh Sachdev spoke exclusively to CNBC-TV18 on his company’s largest round of funding, emphasising on the need to capitalise on the 350-billion-dollar call centre industry as a prime prospect for the implementation of artificial intelligence. “By 2021, nearly 70 percent of this market will integrate with artificial intelligence systems in place,” said Ravi, in agreement, “So, the current focus is to go ahead and capture as much market as possible.”

READ ALSO: Uniphore's Umesh Sachdev expects 300% growth in 2019

Part of the plan to getting this done would be for Uniphore to ramp up investments in product, on a priority. Ravi said that the company’s collaboration with tech institutes like IIT Madras has enabled it to apply special focus to R&D and engineering, to help achieve this quicker.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Westinghouse Electric, Cameco Corp and Brookfield Asset Management in $80 bln nuclear power push
Westinghouse Electric, Cameco Corp and Brookfield Asset Management in $80 bln nuclear power push
Oct 28, 2025
Oct 28 (Reuters) - Westinghouse Electric Company, Cameco Corporation ( CCJ ) and Brookfield Asset Management ( BAM ) entered a partnership with the United States government to build at least $80 billion worth of new nuclear reactors across the country, the companies said on Tuesday. ...
Group 1 Automotive Q3 Adjusted Earnings, Revenue Increase
Group 1 Automotive Q3 Adjusted Earnings, Revenue Increase
Oct 28, 2025
05:29 AM EDT, 10/28/2025 (MT Newswires) -- Group 1 Automotive ( GPI ) reported Q3 adjusted earnings Tuesday of $10.45 per diluted share, up from $9.90 a year earlier. Analysts polled by FactSet expected $10.73. Revenue for the quarter ended Sept. 30 was $5.78 billion, up from $5.22 billion a year earlier. Analysts surveyed by FactSet expected $5.67 billion. ...
Smithfield Foods quarterly sales, profit rise on steady demand for meat
Smithfield Foods quarterly sales, profit rise on steady demand for meat
Oct 28, 2025
Oct 28 (Reuters) - Smithfield Foods ( SFD ) posted a jump in third-quarter revenue and profit on Tuesday, as the U.S. pork processor benefited from resilient demand for higher-priced packaged meats and fresh pork. The company, the biggest U.S. pork processor, has been working to rein in expenses amid a spike in raw material costs and cautious consumer spending....
Novartis looking to add more medicines to direct to patient platform, CEO says
Novartis looking to add more medicines to direct to patient platform, CEO says
Oct 28, 2025
LONDON, Oct 28 (Reuters) - Swiss drugmaker Novartis is exploring options to add more medicines to its direct to patient platform that is expected to launch in the U.S. next month, CEO Vas Narasimhan told Reuters in an interview on Tuesday. We're certainly looking to see if we can add other medicines to the platform, but no concrete plans at...
Copyright 2023-2025 - www.financetom.com All Rights Reserved